A detailed history of Eaton Vance Management transactions in Invitae Corp stock. As of the latest transaction made, Eaton Vance Management holds 100,000 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,000
Previous 100,000 -0.0%
Holding current value
$0
Previous $244,000 0.82%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $6,390 - $27,030
-3,000 Reduced 2.91%
100,000 $244,000
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $3.41 Million - $5.86 Million
103,000 New
103,000 $3.94 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.